HK Stem Cell Regenerative Medicine International Research Institute Co., Limited
瑞宏辉有限公司
HK Stem Cell Regenerative Medicine International Research Institute Co., Limited (瑞宏輝有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its Business Registration Number (BRN) is 79698010, classified as a Private company limited by shares. Incorporated on 2026-01-28, the entity has maintained continuous statutory operations for 1 year, currently holding an active legal status of Live. The registered office is situated at FLAT/RM 1618B 16/F, PIONEER CENTRE, 750 NATHAN ROAD, MONG KOK, HONG KONG. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.
I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 瑞宏輝有限公司 | Official English Name | HK Stem Cell Regenerative Medicine International Research Institute Co., Limited |
|---|---|---|---|
| Business Reg No. (BRN) | 79698010 | Company Reg No. (CR) | — (No CR Registered) |
| Company Category | Private company limited by shares | Incorporation Date | 2026-01-28 |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-01-28 |
| Registered Office Address |
FLAT/RM 1618B 16/F, PIONEER CENTRE, 750 NATHAN ROAD, MONG KOK, HONG KONG
|
||
| Significant Controllers (SCR) | Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers. | ||
II. Companies Registry Statutory Image Records
Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.
| Item | Filing Date | Form Ref. | Document Name | Pages | Format | Fee | Action |
|---|---|---|---|---|---|---|---|
| 1 | 2026-01-28 | A&A |
A&A Statutory Filing
|
32 | ¥28.00 | ||
| 2 | 2026-01-28 | NNC1 |
NNC1 Statutory Filing
|
22 | ¥28.00 | ||
| 3 | 2026-01-28 | NAR1 |
NAR1 Statutory Filing
|
16 | ¥28.00 | ||
| 4 | 2026-01-15 | ND2A |
ND2A Statutory Filing
|
4 | ¥28.00 |
III. Commercial Due Diligence & Regulatory Risk Screening
Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.
IV. Similar Trade Names & Industry Directory
ZHONG JIANAN ENERGY INVES…
中建安能源投资集团有限公司
RICH GRAND CHINA HONG KON…
富华盛(中国香港)有限公司
Rich Home (HK) Internatio…
瑞虹(香港)有限公司
RICH OCEAN INC LIMITED
富洋有限公司
RICHE SUPPLY CHAIN MANAGE…
瑞馳供应链管理(香港)有限公司
Richfull Capital Hong Kon…
瑞復资本香港有限公司